TIANYU PHARM: Rosuvastatin and Ezetimibe Tablets (I) Obtained Drug Registration Certificate
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, TIANYU PHARM announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. ("Nuode Pharmaceutical") recently received the Drug Registration Certificate for Rosuvastatin and Ezetimibe Tablets (I) issued by the National Medical Products Administration (hereinafter referred to as "National Medical Products Administration"). Rosuvastatin and Ezetimibe Tablets (I) are suitable for hypercholesterolemia and homozygous familial hypercholesterolemia (HoFH)
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments